ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA

Clinical trials for ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA explained in plain language.

Never miss a new study

Get alerted when new ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA trials appear

Sign up with your email to follow new studies for ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2

Three-Pronged attack on deadly leukemia aims for cure

⭐️ CURE ⭐️ Recruiting now

This study is testing a combination of three drugs to try to cure patients with a specific, aggressive type of leukemia called acute promyelocytic leukemia (APL). The goal is to see if using these drugs together can eliminate the cancer for good, allowing patients to stop treatme…

Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: ⭐️ CURE ⭐️

Last updated Mar 16, 2026 15:25 UTC

ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA

Get alerted when new ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA trials appear

Three-Pronged attack on deadly leukemia aims for cure